MedPath

Astudy to compare the daily versus monthly oral vitamin D3 in equivalent doses for treatment of vitamin D deficiency in infants.

Phase 3
Conditions
Health Condition 1: E40-E46- MalnutritionHealth Condition 2: E559- Vitamin D deficiency, unspecified
Registration Number
CTRI/2019/10/021549
Lead Sponsor
ady Hardinge Medical College Associated Hospital New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All infants (upto 12 months age) presenting with symptoms compatible with vitamin D

deficiency and documented to have serum vitamin D levels < 20ng/ml. These will include

infants with

- Hypocalcemic seizures

- Clinically & radiologically diagnosed rickets

Exclusion Criteria

-Infant with non â??nutritional rickets

-Infants having known comorbidities affecting vitamin D metabolism like: Diarrhea and

other mal-absorption syndromes, hepatic disorder , renal disorder, infants on

concomitant anticonvulsant therapy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of two treatment regimens will be assessed comparing the proportion of subjects in <br/ ><br>in the 2 groups with <br/ ><br> -Complete normalisation of radiological score for healing of rickets, <br/ ><br>- Normalisation of serum ALP, calcium, Phosphate, PTH & serum 25(OH) D <br/ ><br>Timepoint: at one month, two month and three month after starting treatment <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
The safety of the therapy will be estimated by measuring prevalence of the following <br/ ><br>Hypercalcemia, <br/ ><br>hypercalciurea and Hypervitaminosis DTimepoint: at 1month , 2 months and 3 months after starting treatment
© Copyright 2025. All Rights Reserved by MedPath